Janney Montgomery Scott LLC Exelixis, Inc. Transaction History

Janney Montgomery Scott LLC

$35.8 Billion
Q3 2024

A detailed history of Janney Montgomery Scott LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Janney Montgomery Scott LLC holds 30,399 shares of EXEL stock, worth $1.07 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

30,399

Previous 58,817 48.32%

Holding current value

$1.07 Million

Previous $1.32 Million 40.32%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$21.96 - $27.6 $624,059 - $784,336	-28,418 Reduced 48.32%	30,399 $789,000
Q2 2024 Jul 25, 2024	SELL	$20.34 - $23.73 $39,235 - $45,775	-1,929 Reduced 3.18%	58,817 $1.32 Million
Q1 2024 May 01, 2024	BUY	$20.17 - $23.93 $70,796 - $83,994	3,510 Added 6.13%	60,746 $1.44 Million
Q4 2023 Feb 07, 2024	SELL	$19.25 - $24.13 $22,907 - $28,714	-1,190 Reduced 2.04%	57,236 $1.37 Million
Q3 2023 Nov 08, 2023	SELL	$19.04 - $22.74 $110,793 - $132,324	-5,819 Reduced 9.06%	58,426 $1.28 Million
Q2 2023 Jul 26, 2023	BUY	$18.17 - $20.48 $49,731 - $56,053	2,737 Added 4.45%	64,245 $1.23 Million
Q1 2023 Apr 28, 2023	BUY	$16.3 - $19.41 $63,570 - $75,699	3,900 Added 6.77%	61,508 $1.19 Million
Q4 2022 Feb 01, 2023	BUY	$14.96 - $17.39 $102,595 - $119,260	6,858 Added 13.51%	57,608 $924,000
Q3 2022 Oct 25, 2022	SELL	$15.68 - $22.27 $63,676 - $90,438	-4,061 Reduced 7.41%	50,750 $796,000
Q2 2022 Aug 03, 2022	SELL	$17.44 - $23.16 $86,345 - $114,665	-4,951 Reduced 8.28%	54,811 $1.15 Million
Q1 2022 May 04, 2022	BUY	$17.03 - $22.67 $20,895 - $27,816	1,227 Added 2.1%	59,762 $1.36 Million
Q4 2021 Jan 27, 2022	SELL	$15.84 - $21.88 $162,280 - $224,160	-10,245 Reduced 14.9%	58,535 $1.07 Million
Q3 2021 Oct 29, 2021	BUY	$16.3 - $21.14 $312,259 - $404,978	19,157 Added 38.61%	68,780 $1.45 Million
Q2 2021 Jul 26, 2021	BUY	$17.95 - $25.56 $13,803 - $19,655	769 Added 1.57%	49,623 $904,000
Q1 2021 Apr 27, 2021	BUY	$20.53 - $25.22 $1 Million - $1.23 Million	48,854 New	48,854 $1.1 Million
Q4 2018 Feb 01, 2019	SELL	$13.65 - $21.8 $199,904 - $319,261	-14,645 Closed	0 $0
Q3 2018 Nov 05, 2018	SELL	$15.87 - $22.4 $40,865 - $57,679	-2,575 Reduced 14.95%	14,645 $260,000
Q2 2018 Jul 24, 2018	BUY	$18.56 - $22.45 $76,003 - $91,932	4,095 Added 31.2%	17,220 $371,000
Q1 2018 Apr 19, 2018	BUY	$22.15 - $31.89 $3,765 - $5,421	170 Added 1.31%	13,125 $291,000
Q4 2017 Feb 14, 2018	BUY	$24.23 - $30.93 $313,899 - $400,698	12,955	12,955 $394,000

Others Institutions Holding EXEL

# of Institutions

481

Shares Held

244M

Call Options Held

1.92M

Put Options Held

1.4M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.3B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.

Account

Janney Montgomery Scott LLC Exelixis, Inc. Transaction History